Identification and computational characterization of a recurrent missense FAH variant c.192G > T associated with aberrant splicing in two Pakistani patients affected with hereditary tyrosinemia type 1

Abstract Background Hereditary Tyrosinemia type 1 (HT1) is a rare autosomal recessive metabolic disorder caused by mutations in the fumarylacetoacetate hydrolase ( FAH ) gene, which encodes the fumarylacetoacetate hydrolase (FAH) homodimer enzyme in the tyrosine catabolic pathway. Deficient FAH activity causes accumulation of toxic metabolites in the liver, delineating tyrosinemia phenotypes, including severe hepatorenal disorders, leading to death. This study aimed to perform molecular diagnosis in children presenting with liver disease. Methods The genomic DNA of two Pakistani children suffering from liver disease was subjected to whole-exome sequencing using the NovaSeq 6000 Sequencing System. The sequencing data were analyzed and annotated using EVIDENCE software, and the variants were classified according to the ACMG guidelines. In-silico tools were used to assess the underlying disease mechanisms of the identified variant. Results The pedigrees indicated that both affected children were born to consanguineous parents. The patients presented with liver disease, but the clinical symptoms were complex and overlapping with other chronic liver diseases. Whole-exome sequencing identified a recurrent homozygous FAH variant NM_000137.4:c.192G > T, leading to the diagnosis of HT1 in both children. The identified variant disrupts exon splicing enhancer/exon splicing silencer (ESE/ESS) motifs, causing aberrant splicing and intron retention, leading to a frameshift and premature termination codon. Conclusions This study highlights the significance of whole-exome sequencing in the diagnosis of clinically complex cases of metabolic disorders, especially when metabolite screening is unavailable. Moreover, it should help carrier identification, improve genetic counseling, and prenatal diagnosis in the affected families. The c.192G > T variant’s pathogenicity is attributed to aberrant splicing rather than the missense substitution.

Authors

Publication Details

Journal
Egyptian Journal of Medical Human Genetics
Published
2026-11-14
DOI
https://doi.org/10.1186/s43042-026-00922-9
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Identification and computational characterization of a recurrent missense FAH variant c.192G > T associated with aberrant splicing in two Pakistani patients affected with hereditary tyrosinemia type 1

Muhammad Naeem, Mirza Zain Ul Abideen, Malali Abdul Sattar, Muhammad Almas Hashmi
Egyptian Journal of Medical Human Genetics
Metabolism and Genetic Disorders
article

Identification and computational characterization of a recurrent missense FAH variant c.192G > T associated with aberrant splicing in two Pakistani patients affected with hereditary tyrosinemia type 1

Muhammad Naeem, Mirza Zain Ul Abideen, Malali Abdul Sattar, Muhammad Almas Hashmi
article en

Abstract

Abstract Background Hereditary Tyrosinemia type 1 (HT1) is a rare autosomal recessive metabolic disorder caused by mutations in the fumarylacetoacetate hydrolase ( FAH ) gene, which encodes the fumarylacetoacetate hydrolase (FAH) homodimer enzyme in the tyrosine catabolic pathway. Deficient FAH activity causes accumulation of toxic metabolites in the liver, delineating tyrosinemia phenotypes, including severe hepatorenal disorders, leading to death. This study aimed to perform molecular diagnosis in children presenting with liver disease. Methods The genomic DNA of two Pakistani children suffering from liver disease was subjected to whole-exome sequencing using the NovaSeq 6000 Sequencing System. The sequencing data were analyzed and annotated using EVIDENCE software, and the variants were classified according to the ACMG guidelines. In-silico tools were used to assess the underlying disease mechanisms of the identified variant. Results The pedigrees indicated that both affected children were born to consanguineous parents. The patients presented with liver disease, but the clinical symptoms were complex and overlapping with other chronic liver diseases. Whole-exome sequencing identified a recurrent homozygous FAH variant NM_000137.4:c.192G > T, leading to the diagnosis of HT1 in both children. The identified variant disrupts exon splicing enhancer/exon splicing silencer (ESE/ESS) motifs, causing aberrant splicing and intron retention, leading to a frameshift and premature termination codon. Conclusions This study highlights the significance of whole-exome sequencing in the diagnosis of clinically complex cases of metabolic disorders, especially when metabolite screening is unavailable. Moreover, it should help carrier identification, improve genetic counseling, and prenatal diagnosis in the affected families. The c.192G > T variant’s pathogenicity is attributed to aberrant splicing rather than the missense substitution.

Egyptian Journal of Medical Human GeneticsVol. 27(1)
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon